Fund Holdings5AM Venture Management, LLC

Total Portfolio Value
$376.98M
Total Bought
$61.26M
Total Sold
$25.30M
Net Transaction
+$35.96M
Filing Period:
Securities
SharesValue ($K)
Q3 2023
Q4 2023
Change
Q3 2023
Q4 2023
Weight (%)
Change
BIOHAVEN LTD(BHVN)0399,972+399,972017,1194.54%+17,119
MERUS N V0521,531+521,531014,3423.80%+14,342
CELLDEX THERAPEUTICS INC NEW(CLDX)310,270497,270+187,0008,53919,7225.23%+11,183
PHARVARIS N V
COM
587,600797,600+210,00012,26322,3735.93%+10,109
VIRIDIAN THERAPEUTICS INC(VRDN)410,000586,595+176,5956,28912,7763.39%+6,487
VIKING THERAPEUTICS INC(VKTX)585,000585,00006,47610,8872.89%+4,411
MIRATI THERAPEUTICS INC192,500192,50008,38511,3093.00%+2,924
TYRA BIOSCIENCES INC(TYRA)411,450554,979+143,5295,6667,6862.04%+2,021
AVIDITY BIOSCIENCES INC665,555665,55504,2466,0231.60%+1,777
SPRUCE BIOSCIENCES INC2,364,0002,364,00005,3436,9271.84%+1,584
MERSANA THERAPEUTICS INC1,305,0001,305,00001,6573,0280.80%+1,370
ANAPTYSBIO INC357,733357,73306,4257,6632.03%+1,238
ENLIVEN THERAPEUTICS INC5,160,9755,160,975070,49971,42818.95%+929
VOR BIOPHARMA INC(VOR)6,361,7236,361,723013,48714,3143.80%+827
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)313,210302,630-10,58017,85318,2764.85%+423
CIDARA THERAPEUTICS INC1,134,5111,134,51101,0699010.24%-168
SCPHARMACEUTICALS INC1,200,6471,200,64708,5497,5282.00%-1,021
IMPEL PHARMACEUTICALS INC2,884,7910-2,884,7911,2400-1,240
GH RESEARCH PLC(GHRS)404,404404,40404,0642,3460.62%-1,719
ZENTALIS PHARMACEUTICALS INC490,000490,00009,8297,4241.97%-2,406
HOMOLOGY MEDICINES INC4,535,9194,535,91905,3072,7580.73%-2,549
COGENT BIOSCIENCES INC(COGT)790,440790,44007,7074,6481.23%-3,059
ENTRADA THERAPEUTICS INC4,408,3794,408,379069,65266,52217.65%-3,130
RALLYBIO CORP3,630,7243,630,724012,2368,6772.30%-3,558
DISC MEDICINE INC(IRON)438,442294,221-144,22120,59816,9944.51%-3,604
DIANTHUS THERAPEUTICS INC(DNTH)1,472,2641,472,264020,12615,3124.06%-4,814
ARVINAS INC320,0000-320,0006,2850-6,285
CRINETICS PHARMACEUTICALS IN(CRNX)462,2860-462,28613,7480-13,748
Page 1 of 1